Photodynamic Therapy (PDT) & Macular Degeneration: Description
The photodynamic therapy consists of 2 steps.
- Step of the Photodynamic Therapy:
First, an intravenous photo sensitive light-activated dye (Verteporfin) is administered. The dye spreads throughout the bloodstream and reaches the new, unwanted blood vessels in the retina.
- Step of the Photodynamic Therapy:
After about 15 minutes the drug has reached the eyes and thus the unwanted blood vessels in the retina of the macular degeneration affected area.
Now the second step of the photodynamic therapy irradiates and activates the dye in the blood vessels of the retina for 83 seconds by a non-thermal, microscopic laser (light dose 50 J/cm2, 600 mW/cm2 irradiance). What follows is the so-called Photo thrombosis. The by the laser of the photodynamic therapy activated dye releases a biochemical process in the vessels.Toxins are created which lead to a damage and thus ultimately to the destruction of the blood vessels. Important in the implementation of the photodynamic therapy is that the area surrounding the retina is not damaged.
Since new vessels grow during the photodynamic therapy procedure's following months it is only after about three months possible to determine by a fluorescein angiographic control whether the photodynamic therapy was successful or not.
It should be noted here that only a stabilization of the already deteriorated vision can be achieved with the photodynamic therapy and must be considered a success.
According to studies the photodynamic therapy cannot stop the disease but slow down the progress of macular degeneration. This also means that the photodynamic therapy cannot repair an already happened loss in vision.
back to top